Marijuana Industry

Valens GroWorks Enters Into $1.2m Loan Repayment Agreements

2017-02-16

 Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement  with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.

InMed's Pharmaceuticals Inc. 2017 Prospects

2017-02-16

InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.

Acquisitions on the Rise as Companies Increase Revenue

2017-02-15

The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.

As a result, M&A activity in the market is heading toward exponential growth as well.

 

Mining for Marijuana in Canada

2017-02-15 The Seed Investor

Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.

Investing In A Different Kind Of Oil

2017-02-15

In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry

2017-02-07

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry 07/02/2017 14:30 PALM BEACH, Florida , February 7, 2017 /PRNewswire/ -- The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry.

Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada

2017-02-07

20,142.13 89.71 (0.45%) Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada BEVERLY HILLS, CA--(Marketwired - Feb 7, 2017) - Crown Baus Capital Corp. (the "Company") ( OTC PINK : CBCA ), is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

2017-02-07

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

Crown Baus (OTC:CBCA) to Spend Upwards of $6m on Greenhouse Space

2017-02-07

Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.

Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.

GW Pharma Looks Better Than Ever to Investors

2017-02-07

The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.

GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.

Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production

2017-02-07

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

Invictus MD (CSE:IMH, OTC:IVITF) Acquires 150 acres to Increase Production

2017-02-07

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.

They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

Aphria (TSXV:APH) Graduates to the TSX

2017-02-06

Aphria (TSXV:APH, OTC:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.